Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07669350

Effect of Aquatic Therapy Program on Balance in Children With Spastic Diplegic Cerebral Palsy

1. Evaluate the effect of a structured aquatic therapy programme on static balance in children with spastic diplegic cerebral palsy. 2. Assess the effect of the same programme on dynamic balance in this patient population. 3. Compare balance outcomes between children receiving aquatic therapy and those receiving conventional land-based physiotherapy.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

5 year–12 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

Cerebral palsy (CP) is the most common cause of permanent motor disability in childhood, with spastic diplegia being the most prevalent subtype, characterized by bilateral lower limb spasticity, impaired postural control, and significantly compromised balance - deficits that restrict functional mobility and participation in daily activities. These balance impairments arise from disrupted selective motor control, abnormal muscle tone, reduced proprioceptive integration, and impaired neuromuscular coordination, and represent a central therapeutic target in paediatric rehabilitation. Aquatic therapy exploits the physical properties of water - buoyancy, hydrostatic pressure, warmth, and viscosity - to reduce spasticity, facilitate movement, and promote motor learning in a safe environment, with meta-analytic evidence confirming significant improvements in gross motor function compared to land-based approaches. However, studies specifically targeting balance as a primary outcome in children with spastic diplegic CP remain limited, representing a clinically important gap that this study seeks to address.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Confirmed diagnosis of spastic diplegic cerebral palsy by a paediatric neurologist or developmental paediatrician
  • Age between 5 and 12 years
  • Classified at GMFCS levels I-III
  • Bilateral lower limb spasticity with a Modified Ashworth Scale (MAS) score of ≥ 1

Exclusion criteria

  • Athetoid, ataxic, or mixed-type cerebral palsy
  • GMFCS levels IV or V (non-ambulatory children)
  • Uncontrolled seizure disorder or epilepsy not managed by medication
  • Open wounds, skin infections, or active dermatological conditions contraindicating water immersion
  • Fear of water (aquaphobia) or inability to tolerate the aquatic environment

Treatment and study plan

aquatic therapy

Other

Aquatic therapy is a specialized rehabilitation approach that utilizes the physical properties of water, including buoyancy, hydrostatic pressure, and resistance, to facilitate movement and improve functional performance in children with diplegic cerebral palsy. The aquatic environment reduces weight-bearing demands, allowing safer practice of balance, gait, strength, and motor control activities while minimizing joint stress. Regular aquatic therapy may enhance muscle strength, postural stability, mobility, and overall participation in daily activities.

land exercise program

Other

The control group participated in a conventional land-based exercise program consisting of stretching, strengthening, balance, and functional mobility exercises. The program focused on improving lower-extremity muscle strength, postural control, gait performance, and overall functional abilities through activities performed on a stable surface. Exercises were progressed according to each participant's abilities while maintaining consistency in treatment duration and frequency across the study groups.

Primary outcomes

  1. static balance

    Time frame: baseline

    Static and dynamic balance will be assessed using the Biodex Balance System. Stability indices will be recorded to evaluate postural control and balance performance

Study contacts

Contact information is provided by the study sponsor or research team.

ibrahim A abu ella, Phd

CONTACT

[email protected]

+201008442281

Sponsors and collaborators

Lead sponsor

Delta University for Science and Technology

Other

Registry information

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Jun 25, 2026
Registry last updated
Jun 25, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.